SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 6-K 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of March 2023

 

Commission File Number: 001-39137

 

AnPac Bio-Medical Science Co., Ltd.

 

801 Bixing Street, Bihu County

Lishui, Zhejiang Province 323006

The People’s Republic of China

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  x Form 40-F  ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ¨

 

 

 

 

 

 

EXPLANATORY NOTE

 

On March 23, 2023, the Registrant issued a press release reporting that a NASDAQ Hearing Panel has granted the Registrant continued listing on the NASDAQ Capital Market subject to the requirement that the Registrant demonstrate on or before July 12, 2023, its compliance with the NASDAQ shareholder equity requirement, as outlined in Listing Rule 5550(b)(1).

 

EXHIBIT INDEX

 

Exhibit   Description
     
99.1   Press release dated March 23, 2023

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  AnPac Bio-Medical Science Co., Ltd.
   
  By: /s/Haohan Xu
  Name: Haohan Xu
  Title: Co-Chief Executive Officer
     
Dated: March 23, 2023    

 

 

 

AnPac Bio Medical Science (NASDAQ:ANPC)
Historical Stock Chart
From May 2023 to Jun 2023 Click Here for more AnPac Bio Medical Science Charts.
AnPac Bio Medical Science (NASDAQ:ANPC)
Historical Stock Chart
From Jun 2022 to Jun 2023 Click Here for more AnPac Bio Medical Science Charts.